Breast cancer treatment: immunotherapy more effective in nanotechnology and nanomedicine
Rahul Tiwari March 26, 2025 03:22 PM

Large and good news has come to light about breast cancer, a deadly disease affecting women. Australian researchers are developing the next generation of nanoparters to treat triple-negative breast cancer, which is one of the deadliest forms of breast cancer. According to the Institute of Australian Bi-Engineering and Nano Technology at the University of Queensland, researchers are designing new iron-based nanops, or "nano-edgeuents".

 

Good news about breast cancer

According to AIBN professor Yu Chengzhong, unlike other breast cancer, TNBC lacks protein used in the treatment of other cancers. Which can fit thousands of nanocations in a fiber of a hair. Its purpose is to strengthen the body's immune system against TNBC. According to AIBN professor Yu Chengzhong, unlike other breast cancer, some traditional remedies used against other cancers in TNBC lack the target proteins. Which makes effective treatment a challenge. "Despite immunotherapy, its effectiveness against triple-negative breast cancer is very limited. It does not provide effective treatment. In such a situation, new options are being discovered through research."

Also effective for treating ovarian cancer

Nanops are designed to enhance the activities of white blood cells used by the immune system to fight t-cells in the tumor microscopic environment. This increases the ability of the immune system to identify and attack cancer cells. The five -year research project, launched with a 3 million Australian dollar funding from the National Health and Medical Research Council, aims to make the treatment of breast cancer more effective. This new initiative can pave the way for the treatment of TNBC but also ovarian cancer.

This research will take forward the boundaries of science.

With the experience of more than two decades in nanotechnology and nanomedicine, U hopes that this success will change cancer treatment by making this success more effective. AIBN director Allen Rowan said: "This research will carry forward the boundaries of science and lead to new remedies that will change our way of fighting this cancer. It will become a ray of hope for women struggling between life and death."

© Copyright @2025 LIDEA. All Rights Reserved.